The global rabeprazole sodium market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Rabeprazole is used for the treatment of duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. It is a condition where the stomach produces too much acid. Rabeprazole sodium can also be used together with antibiotics such as amoxicillin, clarithromycin for the treatment of ulcers that are caused by the H. pylori bacteria. Additionally, it is a type of proton pump inhibitor (PPI) that limits the acid that is produced by the stomach. Increasing demand for proton pump inhibitors are primarily contri buting to the growth of the market.
Other major factor driving the growth of the global rabeprazole sodium market is the growing prevalence of gastroesophageal reflux disease (GERD) and ulcers during the forecast period. According to the National Center for Biotechnology Information, GERD is one of the most common gastrointestinal disorders which has a prevalence of approximately 20% of adults in the US. Hence, the growing prevalence of this disease is driving the growth of the market. However, side effects such as sore throat, headaches, gas, and diarrhea are expected to hamper the growth of the market.
To Request a Sample of our Report on Rabeprazole Sodium Market: https://www.omrglobal.com/request-sample/rabeprazole-sodium-market
Some major players in the market include Pfizer Inc., Novartis International AG (Sandoz Inc.), and Teva Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2021, Woodward Pharma Services LLC has acquired AcipHex (rabeprazole sodium) from Eisai Co., Ltd.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
· By Type
· By Application
• Regions Covered–
· North America
· Europe
· Asia-Pacific
· Rest of the World
• Competitive Landscape-Pfizer Inc., Novartis International AG (Sandoz Inc.), and Teva Pharmaceutical Industries Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Rabeprazole Sodium Market is Available at: https://www.omrglobal.com/industry-reports/rabeprazole-sodium-market
Global Rabeprazole Sodium Market Report by Segment
By Type
• Rabeprazole Sodium Monohydrate
• Rabeprazole Sodium Crystalline
By Application
• Gastroesophageal Reflux Disease Treatment
• Duodenal Ulcer Treatment
• Others
Global Rabeprazole Sodium Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
